Logo image of ESON.LS

ESTORIL SOL SGPS SA-REG SHS (ESON.LS) Stock Fundamental Analysis

ELI:ESON - Euronext Lisbon - PTESO0AM0000 - Common Stock - Currency: EUR

4.3  0 (0%)

Fundamental Rating

2

Overall ESON gets a fundamental rating of 2 out of 10. We evaluated ESON against 0 industry peers in the Unkown industry. The financial health of ESON is average, but there are quite some concerns on its profitability. ESON has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ESON has reported negative net income.
ESON had a positive operating cash flow in the past year.
ESON had positive earnings in 4 of the past 5 years.
Of the past 5 years ESON 4 years had a positive operating cash flow.
ESON.LS Yearly Net Income VS EBIT VS OCF VS FCFESON.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

The last Return On Invested Capital (3.34%) for ESON is well below the 3 year average (13.45%), which needs to be investigated, but indicates that ESON had better years and this may not be a problem.
Industry RankSector Rank
ROA -2.48%
ROE -6.68%
ROIC 3.34%
ROA(3y)9.62%
ROA(5y)3.75%
ROE(3y)14.71%
ROE(5y)5.57%
ROIC(3y)13.45%
ROIC(5y)N/A
ESON.LS Yearly ROA, ROE, ROICESON.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

1.3 Margins

ESON's Profit Margin has declined in the last couple of years.
ESON's Operating Margin has improved in the last couple of years.
In the last couple of years the Gross Margin of ESON has remained more or less at the same level.
Industry RankSector Rank
OM 10.01%
PM (TTM) N/A
GM 98.16%
OM growth 3YN/A
OM growth 5Y1.99%
PM growth 3YN/A
PM growth 5Y-18.34%
GM growth 3Y-0.1%
GM growth 5Y0.24%
ESON.LS Yearly Profit, Operating, Gross MarginsESON.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ESON is creating some value.
ESON has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ESON remains at a similar level compared to 5 years ago.
Compared to 1 year ago, ESON has an improved debt to assets ratio.
ESON.LS Yearly Shares OutstandingESON.LS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ESON.LS Yearly Total Debt VS Total AssetsESON.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 1.00, we must say that ESON is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of ESON is 0.29, which is an excellent value as it means it would take ESON, only 0.29 years of fcf income to pay off all of its debts.
ESON has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Even though the debt/equity ratio score it not favorable for ESON, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.29
Altman-Z 1
ROIC/WACC0.37
WACC9.04%
ESON.LS Yearly LT Debt VS Equity VS FCFESON.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.62 indicates that ESON should not have too much problems paying its short term obligations.
A Quick Ratio of 1.43 indicates that ESON should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.43
ESON.LS Yearly Current Assets VS Current LiabilitesESON.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

ESON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -135.34%.
ESON shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.29% yearly.
The Revenue for ESON has decreased by -14.21% in the past year. This is quite bad
ESON shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.52% yearly.
EPS 1Y (TTM)-135.34%
EPS 3YN/A
EPS 5Y-16.29%
EPS Q2Q%-194.48%
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y17.83%
Revenue growth 5Y2.52%
Sales Q2Q%-12.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ESON.LS Yearly Revenue VS EstimatesESON.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ESON. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ESON.LS Price Earnings VS Forward Price EarningsESON.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 29.21
EV/EBITDA N/A
ESON.LS Per share dataESON.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

ESON has a Yearly Dividend Yield of 3.90%.
ESON's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 3.9%

5.2 History

The dividend of ESON is nicely growing with an annual growth rate of 18.43%!
Dividend Growth(5Y)18.43%
Div Incr Years0
Div Non Decr Years0
ESON.LS Yearly Dividends per shareESON.LS Yearly Dividends per shareYearly Dividends per share 2019 2024 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of ESON are negative and hence is the payout ratio. ESON will probably not be able to sustain this dividend level.
DP-145.2%
EPS Next 2YN/A
EPS Next 3YN/A
ESON.LS Yearly Income VS Free CF VS DividendESON.LS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

ESTORIL SOL SGPS SA-REG SHS

ELI:ESON (6/18/2025, 7:00:00 PM)

4.3

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap51.56M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.9%
Yearly Dividend1.3
Dividend Growth(5Y)18.43%
DP-145.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF 29.21
P/OCF 2.02
P/B 0.44
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY3.42%
OCF(TTM)2.13
OCFY49.46%
SpS9.49
BVpS9.88
TBVpS-5.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.48%
ROE -6.68%
ROCE 4.23%
ROIC 3.34%
ROICexc 4.49%
ROICexgc 50.66%
OM 10.01%
PM (TTM) N/A
GM 98.16%
FCFM 1.55%
ROA(3y)9.62%
ROA(5y)3.75%
ROE(3y)14.71%
ROE(5y)5.57%
ROIC(3y)13.45%
ROIC(5y)N/A
ROICexc(3y)48.44%
ROICexc(5y)N/A
ROICexgc(3y)112.04%
ROICexgc(5y)N/A
ROCE(3y)17.45%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y29.92%
ROICexc growth 3YN/A
ROICexc growth 5Y-19.41%
OM growth 3YN/A
OM growth 5Y1.99%
PM growth 3YN/A
PM growth 5Y-18.34%
GM growth 3Y-0.1%
GM growth 5Y0.24%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.29
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 20.85%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.43
Altman-Z 1
F-Score4
WACC9.04%
ROIC/WACC0.37
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)12.27%
Cap/Sales(5y)7.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-135.34%
EPS 3YN/A
EPS 5Y-16.29%
EPS Q2Q%-194.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y17.83%
Revenue growth 5Y2.52%
Sales Q2Q%-12.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-64.59%
EBIT growth 3YN/A
EBIT growth 5Y4.56%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-95.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.71%
OCF growth 3YN/A
OCF growth 5Y-2.54%